PRVA vs ATKR
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
PRVA · Privia Health$25.05 ▲ 1.46%
ATKR · Atkore$0.00 ▲ 0.00%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- PRVA -6.1%
- ATKR +54.8%
Head to head
| Metric | PRVA | ATKR |
|---|---|---|
| Price | $25.05 | $0.00 |
| Change today | ▲ 1.46% | ▲ 0.00% |
| Market cap | $3.20B | $3.21B |
| Return, 3 months | +19.2% | +29.8% |
| Return, year to date | +5.7% | +52.1% |
| Return, 1 year | +5.5% | +48.3% |
| P/E (TTM) | 96.3 | – |
| P/B | 3.9 | 2.5 |
| P/E percentile vs own 5y | 43rd | 14th |
| Dividend yield | – | 1.39% |
| Revenue growth (YoY, latest qtr) | +13.2% | +8.1% |
| Net profit growth (YoY) | +48.8% | -98.3% |
| Gross margin | 9.9% | 20.0% |
| Operating margin | 2.1% | 4.6% |
| Net margin | 1.4% | -5.5% |
| Return on equity | 4.6% | -11.9% |
| Analyst target vs. price | +21.8% | – |
| Analyst buy share | 83% | 0% |
| RSI (14) | 67 | 73 |
| 30-day volatility | 35.2% | 2.1% |
| Max drawdown, 1 year | -32.0% | -24.4% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- ATKR is the largest of the group by market value.
- ATKR has returned the most over the past year.
- PRVA is growing revenue fastest.
- PRVA keeps the most profit per dollar of sales.
- ATKR has been the calmest stock over the last 30 days.